Company / Working Capital per Share
Travere Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.17
FY2025
5-year range
$2.87 / $8.78
FY2021-FY2025
Trend
+10.8%
vs FY2024
Sector context
#136 of 210
Health Care
What the data says
At $3.17, Travere Therapeutics, Inc.'s working capital per share ranks #136 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $2.87 in FY2024 to $9.93 in FY2018.
Based on SEC 10-K filings.
3.17 in FY2025 with a 5-year CAGR of -15.5%.
Declined from $6.83 to $3.17 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -16.8%
- 5-Year CAGR
- -15.5%
- 10-Year CAGR
- -
Sector benchmark
#136 of 210 in Health CareTop 65% of 210This company $3.17 Sector average $146.86
▼
-97.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 10.8% year-over-year.
- Ranks #136 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2018.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.17 | +10.8% |
| FY2024 | $2.87 | -58.0% |
| FY2023 | $6.83 | +23.9% |
| FY2022 | $5.51 | -37.3% |
| FY2021 | $8.78 | +19.1% |
| FY2020 | $7.37 | -8.5% |
| FY2019 | $8.06 | -18.8% |
| FY2018 | $9.93 | +56.8% |
| FY2017 | $6.34 | -7.3% |
| FY2016 | $6.83 | -17.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026